A systematic review of value-based health care delivery models in oncology care found that reports of outcomes are often lacking and show varying degrees of quality improvement.
Rates of survival have increased in patients with stage III to IV Hodgkin lymphoma over 3 decades as a result of improvements in the United States health care system.
A new real-world study compared the health care resource utilization and costs between patients treated for multiple myeloma with and without renal impairment.
An economic model comparing different types of genetic testing in metastatic non-small cell lung cancer showed that next-generation sequencing is more cost-effective than testing for one or a limited number of genes at a given time.
The National Comprehensive Cancer Network has issued updates to their clinical practice guidelines, drugs and biologics compendium, radiation therapy compendium, and imaging appropriate use criteria guidelines for pancreatic adenocarcinoma.
Richard Kane, MIPP, MA, and Josh Seidman, PhD, MHS, both with Avalere Health, share their thoughts on the intricacies of the MACRA Merit-Based Incentive Payment System and the risk practices must accept when transitioning to the Oncology Care Model.
The National Comprehensive Cancer Network has released a free resource to help patients with acute myeloid leukemia and their families become better informed in treatment decision-making.
Four risk prediction models have been shown to accurately select the highest risk smokers for lung cancer screening.
A new study found that timely reporting of palliative care needs may lead to less aggressive therapy and end-of-life care among patients with non-small cell lung cancer.
Catch up on some of the most recent and practice-changing guideline updates in blood malignancies regarding treatment approaches and prognostic indicators.